Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ACRV compared with SGP: revenue, margins and what each company keeps, and the suppliers and customers both name
ACRV
Acrivon Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
SGP
SpyGlass Pharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ACRV
Acrivon Therapeutics, Inc.
vs
SGP
SpyGlass Pharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
ACRV
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▲
+7.56%
—
SGP
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▲
+2.26%
—
= implied
ACRV realized, solid
SGP realized, hatched
One scale, both sides: full bar = 8%
× = |realized| ÷ implied
Source: market data
ACRV
Acrivon Therapeutics, Inc.
Change
1.61
▼
−3.01%
· post 1.61
· delayed
Mkt cap
$12.5M
SGP
SpyGlass Pharma, Inc.
Change
32.97
▲
+2.25%
· post 32.97
· delayed
After hours
Nov 2 '26
delayed
Mkt cap
$1.1B
vs
Compare
After hours
Nov 2 '26
delayed
ACRV
Acrivon Therapeutics, Inc.
vs
SGP
SpyGlass Pharma, Inc.
1.61
▼
−3.01%
post 1.61
delayed
Price
32.97
▲
+2.25%
post 32.97
delayed
$12.5M
Mkt cap
$1.1B
Change
Change
ACRV
1.61
▼
−3.01%
vs
SGP
32.97
▲
+2.25%
After hours
Nov 2 '26
delayed